Laboratoire de recherche NAFLD et résistance à l'insuline

Partager Imprimer
Titre
Secrétariat d'endocrinologie et diabétologie
Adresse

Rue Gabrielle Perret-Gentil 4
1205 Genève
Suisse

Complément d'adresse
Bâtiment d'appui, 7ème étage
Titre
Secrétariat de l'unité de nutrition
Adresse

Rue Gabrielle Perret-Gentil 4
1205 Genève
Suisse

Titre
Secrétariat de l'unité d'éducation thérapeutique
Adresse

Chemin Venel 7
1206 Genève
Suisse

Titre
Secrétariat de lipidologie
Adresse

Rue Gabrielle Perret-Gentil 4
1205 Genève
Suisse

Responsable : Pr François JORNAYVAZ

Groupe de recherche

  • Dr Emmanuel SOMM, biologiste, collaborateur scientifique 
  • Mme Elodie PERROUD, laborantine 
  • Dr Karim GARIANI, Privat-Docent, médecin chef de clinique 

Our lab is mainly focused on the link between nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) and insulin resistance, which represents a key step in the development of type 2 diabetes. The topic is of importance and clinically relevant since type 2 diabetes is projected to increase and affect 592 million people worldwide by 2035. NAFLD/NASH is a very important disease and now represents the most frequent chronic liver disease worldwide. It is estimated to affect up to 60 to 70% of people with type 2 diabetes. Moreover, NAFLD represents the hepatic manifestation of the metabolic syndrome and as such represents a cardiovascular risk factor. The aims of the lab are therefore to: identify patients with NAFLD; identify which patients will present progression of their hepatic disease; and find therapeutic targets to prevent and heal NAFLD/NASH. To these ends, we use a translational approach using cell cultures, in vivo animal models and humans.

Groupe de recherche

Consultez le biosketch et les publications

Dernière mise à jour : 07/10/2021